Medicine and Dentistry
Systematic Review
100%
Infection
100%
Meta-Analysis
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Primary Prevention
50%
COVID-19 Vaccine
50%
Omicron Coronavirus Variant
42%
Observational Study
19%
COVID-19
18%
Ivermectin
12%
Hydroxychloroquine
12%
ACE Inhibitor
12%
Clinical Trial
12%
Angiotensin Receptor Antagonist
12%
Vulnerable Population
7%
Diseases
7%
Intensive Care Unit
7%
Intervention Study
6%
Disease
6%
Statin
6%
Drug Repositioning
6%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
SARS Coronavirus
100%
Observational Study
69%
Multiple Sclerosis
50%
Side Effect
50%
Randomized Controlled Trial
50%
COVID-19 Vaccine
50%
Clinical Study
50%
Clinical Trial
12%
Disease
12%
Angiotensin Receptor Antagonist
12%
Hydroxychloroquine
12%
Dipeptidyl Carboxypeptidase Inhibitor
12%
Ivermectin
12%
Diseases
7%
Drug Repositioning
6%
Pharmacotherapy
6%
Statin (Protein)
6%
Intervention Study
6%
Normal Human
6%
Recurrence Risk
6%
Keyphrases
Severe Outcomes
50%
Meta-analysis
50%
COVID-19 Vaccine
50%
Systematic Meta-analysis
50%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
50%
Infection Outcome
50%
European Studies
50%
Vaccine Effectiveness
50%
Real-word Evidence
33%
Primary Series
22%
Manifold Approximation
16%
Manifold Projection
16%
Semantically Similar Sentences
16%
Posterior Predictive Distribution
12%
Omicron Strain
11%
Hydroxychloroquine Prophylaxis
8%
Intensive Care Unit Admission
5%
% Protection
5%
European Population
5%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
5%
Viral mutation
5%
Hospitalization
5%
Preventing Infection
5%
Vulnerable Populations
5%
Booster Vaccination
5%
Random-effects Meta-analysis
5%
PubMed
5%
Omicron Variant
5%
Time-variant
5%
Embase
5%
Severe Disease
5%
Europe
5%
Infectious Diseases
5%
